Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA03110011 | 5-iPF2α-VI | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 0.82 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 0.88 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 0.9 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 0.89 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 0.92 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 1.28 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 1.06 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 1.67 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | C | 0.0 | BCD100427B001 | 1.79 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | C | 0.5 | BCD100427B003 | 1.2 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | C | 1.0 | BCD100427B007 | 1.51 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | C | 2.0 | BCD100427B011 | 1.73 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | C | 4.0 | BCD100427B015 | 1.28 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | C | 8.0 | BCD100427B019 | 2.08 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | C | 12.0 | BCD100427B023 | 2.22 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | C | 24.0 | BCD100427B027 | 3.02 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 0.91 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 0.65 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 0.92 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 0.93 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 1.21 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 1.35 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 1.59 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol | 0.5 | BCD100427B004 | 1.51 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol | 1.0 | BCD100427B008 | 1.49 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol | 2.0 | BCD100427B012 | 1.83 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol | 4.0 | BCD100427B016 | 1.68 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol | 8.0 | BCD100427B020 | 2.03 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol | 12.0 | BCD100427B024 | 2.14 | pmol/sample |
| LMFA03110011 | 5-iPF2α-VI | 25OH-Chol | 24.0 | BCD100427B028 | 2.47 | pmol/sample |